Klp Kapitalforvaltning As Novo Cure LTD Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Novo Cure LTD stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 21,600 shares of NVCR stock, worth $468,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,600Holding current value
$468,936% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
284Shares Held
75.5MCall Options Held
1.28MPut Options Held
350K-
Black Rock Inc. New York, NY12.1MShares$263 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$256 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$193 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$105 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$60.9 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.28B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...